December 1, 2011
Table of Contents
As an action-packed year for the HIV/AIDS community draws to a close, TheBody.com takes stock of 2011 in a new series of articles, "2011 HIV/AIDS Year in Review." Read the entire series here.
A year can seem like a long time. When our planet was last where it is now relative to the sun, the spewing remnants of the BP Deepwater Horizon rig had just been capped, mid-term elections handed the GOP the keys to the House, and a new-fangled device called the iPad had been in stores for only a few months. In our smaller orbit of HIV-related news, it can be hard to appreciate where we were just a year ago. Below are some of the stories that marked our journey through 2011 and, in some way, changed things from the way they used to be.
No comments have been made.
|Taking Atripla Three Days a Week Maintains Undetectable HIV Viral Load, Pilot Study Finds|
|Which HIV Treatment Regimens Are Recommended for Newly Diagnosed Patients?|
|Weekly PRO 140 Antibody Injections May Work as HIV Maintenance Therapy|
|This Week in HIV Research: Effects of Treatment on Arterial Inflammation; Mortality Rate After 5 Years of Treatment Not Impacted by Initial CD4 Count|
|Investigational Integrase Inhibitor Bictegravir Safe and Effective Against HIV in Early Study|